These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11390018)

  • 1. Blockade of pancreatic polypeptide-sensitive neuropeptide Y (NPY) receptors by agonist peptides is prevented by modulators of sodium transport. Implications for receptor signaling and regulation.
    Parker MS; Berglund MM; Lundell I; Parker SL
    Peptides; 2001 Jun; 22(6):887-98. PubMed ID: 11390018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of rabbit kidney and brain pancreatic polypeptide-binding neuropeptide Y receptors: differences with Y1 and Y2 sites in sensitivity to amiloride derivatives affecting sodium transport.
    Parker SL; Parker MS; Crowley WR
    Regul Pept; 1999 Jun; 82(1-3):91-102. PubMed ID: 10458651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
    Widdowson PS; Buckingham R; Williams G
    Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
    Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
    J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor.
    Parker SL; Kane JK; Parker MS; Berglund MM; Lundell IA; Li MD
    Eur J Biochem; 2001 Feb; 268(4):877-86. PubMed ID: 11179953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Y1, Y2 and Y5 subtypes of the neuropeptide Y (NPY) receptor in rabbit kidney. Sensitivity of ligand binding to guanine nucleotides and phospholipase C inhibitors.
    Parker SL; Parker MS; Crowley WR
    Regul Pept; 1998 Sep; 75-76():127-43. PubMed ID: 9802402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand association with the rabbit kidney and brain Y1, Y2 and Y5-like neuropeptide Y (NPY) receptors shows large subtype-related differences in sensitivity to chaotropic and alkylating agents.
    Parker SL; Parker MS
    Regul Pept; 2000 Feb; 87(1-3):59-72. PubMed ID: 10710289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor.
    Schober DA; Van Abbema AM; Smiley DL; Bruns RF; Gehlert DR
    Peptides; 1998; 19(3):537-42. PubMed ID: 9533642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways.
    Misra S; Murthy KS; Zhou H; Grider JR
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1154-62. PubMed ID: 15308651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
    Misra S; Mahavadi S; Grider JR; Murthy KS
    Regul Pept; 2005 Feb; 125(1-3):163-72. PubMed ID: 15582728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FMRFamides exert a unique modulation of rodent pancreatic polypeptide sensitive neuropeptide Y (NPY) receptors.
    Parker SL; Parker MS
    Can J Physiol Pharmacol; 2000 Feb; 78(2):150-61. PubMed ID: 10737678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
    King PJ; Widdowson PS; Doods HN; Williams G
    J Neurochem; 1999 Aug; 73(2):641-6. PubMed ID: 10428060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NPY receptor subtype in the rabbit isolated ileum.
    Félétou M; Nicolas JP; Rodriguez M; Beauverger P; Galizzi JP; Boutin JA; Duhault J
    Br J Pharmacol; 1999 Jun; 127(3):795-801. PubMed ID: 10401572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic polypeptide receptors: affinity, sodium sensitivity and stability of agonist binding.
    Parker MS; Lundell I; Parker SL
    Peptides; 2002 Feb; 23(2):291-303. PubMed ID: 11825644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-regulation of agonist activity at the Y receptors.
    Parker SL; Parker MS; Sah R; Balasubramaniam A; Sallee FR
    Peptides; 2007 Feb; 28(2):203-13. PubMed ID: 17194507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of pancreatic polypeptide-sensitive neuropeptide Y (NPY) receptors in estrogen-induced hypertrophy of the anterior pituitary gland in the Fischer-344 rat.
    Parker MS; Wang JJ; Fournier A; Parker SL
    Mol Cell Endocrinol; 2000 Jun; 164(1-2):239-49. PubMed ID: 11026575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
    Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
    Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.